Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synthetic peptides: prospects for vaccine development.

D R Milich1

  • 1Department of Molecular Biology, Research Institute of Scripps Clinic, La Jolla, CA 92037.

Seminars in Immunology
|September 1, 1990
PubMed
Summary

Synthetic peptides offer a stable, cost-effective vaccine source, stimulating key immune cells. However, challenges remain in their application for effective vaccine design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Human vaccines & immunotherapeutics·2019
Same author

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

Gut·2006
Same author

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Gut·2005
Same author

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.

Vaccine·2001
Same author

Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant.

Journal of immunological methods·2001
Same author

Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Antiviral research·2001

Area of Science:

  • Immunology
  • Vaccine Development
  • Synthetic Chemistry

Background:

  • Synthetic peptides are increasingly explored for vaccine development due to their stability and cost-effectiveness.
  • These synthetic antigens can elicit immune responses from T helper cells, cytotoxic T cells, and B cells against native proteins.

Purpose of the Study:

  • To review the current understanding of peptide antigens as immunogens.
  • To analyze the advantages and disadvantages of using synthetic peptides in vaccine design.

Main Methods:

  • Literature review of studies on synthetic peptide antigens.
  • Analysis of immunogenicity data for synthetic peptides.
  • Evaluation of challenges and benefits in peptide-based vaccine formulation.

Main Results:

  • Chemical synthesis provides a reliable and affordable supply of peptide antigens.
  • Synthetic peptides can successfully prime various immune cell populations.
  • Obstacles to the widespread use of peptide antigens in vaccines have been identified.

Conclusions:

  • Synthetic peptides hold significant promise for vaccine applications.
  • Further research is needed to overcome existing limitations for optimal vaccine design.

Related Experiment Videos